Zevra Therapeutics, Inc. ZVRA Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s total costs & expenses?
- Zevra Therapeutics, Inc. (ZVRA) reported total costs & expenses of $25.18M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s total costs & expenses changed year-over-year?
- Zevra Therapeutics, Inc.'s total costs & expenses increased by 10.4% year-over-year, from $22.8M to $25.18M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s total costs & expenses has grown at a 44.2% compound annual growth rate (CAGR), from $20.92M to $90.36M.
- What does total costs & expenses mean?
- This metric aggregates all operating costs incurred to support the business, including cost of product revenue, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's operational burn rate and efficiency in managing its cost structure. Tracking this helps evaluate the scalability of the business model relative to revenue growth.